Tristel PLC
29 October 2007
Tristel PLC ('Tristel')
Dividend
Further to today's earlier announcement, Tristel, the AIM listed provider of
infection and contamination control products, confirms that it will pay its full
year dividend of 1p per ordinary share to shareholders on the register as at 16
November 2007. The ordinary shares will be marked ex dividend on 14 November
2007 and shareholders will be paid on 14 December 2007.
Enquiries:
Tristel plc Tel: 01638 721 500
Paul Swinney
Chief Executive
Daniel Stewart & Company Plc Tel: 020 7776 6550
Graham Webster
Parkgreen Communications Limited Tel: 020 7479 7933
Paul.McManus
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.